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Abstract: There is limited information on the occurrence of respiratory events in postoperative 
patients after discharge from the postanesthesia care unit. We studied the respiratory rate (RR) 
of 68 patients aged 60 years and above during the first 6 hours following elective surgery under 
general anesthesia to assess the frequency of respiratory events in the care unit and on the ward. RR 
was derived from the continuous RR counter RespiR8, measuring RR by quantifying the humidity 
of exhaled air. One-minute-averaged RRs were collected and analyzed to assess the frequency of 
postoperative bradypnea (RR 1–6 breaths/minute) and apnea (cessation of inspiratory flow $60 
seconds). Values were median (interquartile range) or mean (SD). The median RR was 13 (10–15) 
breaths/minute. In the 6-hour postoperative period, 78% and 57% of patients experienced at least 
one bradypnea or apnea event, respectively. A median of ten (3.5–24) bradypnea and three (1–11) 
apnea events were detected per patient. The occurrence of respiratory events in the postanesthesia 
care unit (PACU) was a predictor of events on the ward (bradypnea, r2=0.4, P,0.001; apnea, 
r2=0.2, P,0.001). Morphine consumption correlated weakly with respiratory events in the PACU, 
but not on the ward. Patients with apnea had significantly larger neck circumference than patients 
without (39.6 [0.7] versus 37.4 [0.8] cm, P,0.05). Bradypneic or apneic respiratory events are 
frequent in postoperative elderly patients and even occur relatively late after surgery. Continuous 
respiratory monitoring on the ward, especially in patients with risk factors, such as early occur-
rence of events, opioid use, and larger neck circumference, is likely warranted.
Keywords: aged, monitoring, physiologic, postoperative period, respiratory insufficiency, 
respiratory rate
Introduction
In current clinical practice, moderate–severe pain in postoperative patients is treated 
with potent opioids. While effective against pain in most patients, opioids come 
with serious side effects, of which opioid-induced respiratory depression is poten-
tially life-threatening.1 In a review of the literature, we recently retrieved 132 case 
studies since 1980 in adult and pediatric patients that described the occurrence of 
postoperative respiratory depression from opioid treatment.2,3 Apart from these case 
studies, there was limited information on the prevalence of respiratory events in the 
postoperative period, with a few studies using continuous monitoring beyond mea-
surements in the postanesthesia care unit (PACU) that showed frequent episodes of 
hypoxemia and/or bradypnea.4,5 In clinical practice, measurements are often restricted 
to the PACU, where currently pulse oximetry is the most important monitor of 
ventilation. However, oxygen saturation is not a direct measure of ventilation (but 
a measure of gas exchange in the lungs), and supplemental oxygen may obscure or 
delay the detection of respiratory events when oxygen saturation is used as a proxy for 
respiratory depression.6
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Given these facts, continuous measurement of ventilation, 
rather than oxygen saturation, is presumably a more accu-
rate tool to detect respiratory events, and also to prevent 
such events.2,4,7,8 A practical method to determine breath-
ing activity is to measure respiratory rate (RR). RR can be 
assessed by multiple methods, including intermittent manual 
counting of thoracic movement and electrocardiography 
(ECG)-derived technologies, which are both error-prone 
and may lead to the underdetection of respiratory events.9 
For example, upper-airway obstruction is often not detected, 
due to the persistence of thoracic movements. Continuous 
monitoring of respiration is thus best accomplished by elec-
tronic devices detecting airflow at the mouth, as this gives 
a noninvasive indication of gas movement into and out of 
the lungs.
In the current study we measured RR in postoperative 
patients using the RespiR8 (Anaxsys, Send, UK), which 
was developed to measure RR based on the humidity of 
exhaled air. In a previous validation study, we showed that 
the RespiR8 monitor is as reliable as capnometry to measure 
RR in the range observed in clinical practice.9 Here, we 
measured RR during the 6 hours following surgery in the 
PACU, as well as on the ward. We tested an elderly popu-
lation, 60 years of age and older, as there is evidence that 
elderly patients are at an elevated risk of respiratory events 
following opioid administration.10 Our main aim was to use 
continuous RR monitoring of the postoperative patient using 
the RespiR8 device in the PACU and on the ward to quantify 
the occurrence of respiratory events, split into bradypneic 
(RR 1–6 breaths/minute) and apneic (RR 0 breaths/minute for 
at least 1 minute) events. Additionally, we aimed to identify 
patient risk factors, such as neck circumference or body-mass 
index, that could predict the occurrence of an event.
Materials and methods
study design and population
The protocol was approved by the Ethics Committee of 
Leiden University Medical Center (the Netherlands) and by 
the National Research Ethics Service Committee, East Mid-
lands (UK). All study procedures were conducted according 
to Good Clinical Practice guidelines and adhered to the tenets 
of the Declaration of Helsinki. This was a multicenter study 
performed at two sites: LUMC, Leiden, the Netherlands, and 
Nottingham University Hospital NHS Trust (Nottingham, 
UK). The study has been registered in the Netherlands Trial 
Register (NTR4778).
Of 115 recruited patients at the preoperative screening 
facility, 80 patients were enrolled in the study. All 80 study 
participants provided oral and written informed consent prior 
to study procedures and prior to their scheduled surgery. 
Inclusion criteria were age $60 years, elective surgery 
under general anesthesia for at least 60 minutes, and ability 
to read and understand the patient-information and consent 
form. Exclusion criteria were head, neck, and facial surgery 
or other conditions prohibiting application of the RespiR8 
mask postoperatively. Possible risk factors for apnea were 
recorded, such as sex, body-mass index, neck circumference, 
history of snoring, or diagnosis of obstructive sleep apnea. 
It was expected that at least 50 subjects would be required 
to observe a significant proportion of patients with at least 
one apnea event.
Measurements
All patients were extubated in the operating theater and 
transported to the PACU. In the PACU, patients were con-
nected to standard clinical monitoring equipment, including 
three-lead ECG and pulse oximetry. All patients received 
conventional clinical care in the PACU facility, and were 
discharged to the ward based on local protocol.
RR was measured automatically and continuously using 
the RespiR8 monitor. The device performs a calculation 
using a three-breath averaging algorithm, and is expressed 
as breaths/minute. The RespiR8 sensor is integrated in a 
standard oxygen face mask that is placed upon arrival in the 
PACU, but does not functionally require a flow of exogenous 
oxygen. In cases where supplemental oxygen was required 
(ie, oxygen saturation ,94%), 5–10 L/minute oxygen was 
administered. Supplemental oxygen was stopped before 
patients were discharged to the ward. RR measurements 
continued on the ward, and were temporarily discontinued in 
cases of eating/drinking, talking, or during other conditions 
where the face mask was removed. A research nurse remained 
with the patient during the complete 6-hour study period. 
Data were digitally recorded as average breaths/minute, 
and each data point represents a 1-minute average. A visual 
alarm was triggered when bradypnea (1–6 breaths/minute) 
or apnea (0 breaths/minute) was detected.
statistical analysis
Statistical testing was performed using GraphPad Prism 6 
(GraphPad Software, La Jolla, CA, US) and SPSS 20 (IBM, 
Armonk, NY, US). Data are presented as average ± standard 
deviation or median (interquartile range), unless otherwise 
stated. Bradypnea was defined as an RR of 1–6 breaths/minute, 
and apnea was defined as an absence of inspiratory flow at 
the mouth for at least 1 minute. Comparisons were made by 
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Student’s t-tests or nonparametric tests, and linear regression 
was used to correlate described variables. P-values ,0.05 
were considered significant.
Results
Of the 80 patients enrolled in the study, data from 68 patients 
were able to be used for analysis. One patient was admit-
ted to the intensive care unit directly after surgery and thus 
excluded; data acquisition failed in four patients, and seven 
patients withdrew their informed consent postoperatively. 
Characteristics of the remaining 68 patients are given in 
Table 1. Ten patients were recruited at the UK site, and 
58 patients were recruited at the Netherlands site.
All patients received general anesthesia; 19 patients 
(28%) received an additional epidural or local technique. 
These 19 patients did not receive additional opioids 
in the operating theater or in the PACU. Of the remaining 
49 patients, 35 (71%) received intravenous morphine as an 
opioid for postoperative pain relief. Typically, they received 
an opioid loading dose during surgery and received further 
increments of morphine titrated to their need in the PACU. 
Five patients subsequently received an intravenous patient-
controlled morphine device; four of these patients used the 
device on the ward. Consequently, of the entire study popula-
tion, only four patients used additional opioids on the ward. 
Patients who did not receive any opioids postoperatively 
were treated with acetaminophen and nonsteroidal anti-
inflammatory agents at regular intervals (see also Table 1). 
Patients who received a muscle relaxant during surgery were 
adequately monitored and effectively reversed with either 
sugammadex or neostigmine according to standardized 
clinical protocol.
No serious adverse events occurred during the study. 
Nine adverse events were recorded, which were all judged 
to be not study-related. Adverse events included nausea and 
the occurrence of moderate pain, all occurring on the ward. 
All events were treated and resolved within the study period: 
pain was treated with a nonsteroidal anti-inflammatory agent, 
nausea with antiemetic medication.
RR monitoring using the RespiR8 device was successful 
during the first 6 postoperative hours. Almost 24,000 RR 
data points were collected (408 hours, 6 hours per patient); 
482 data points (ie, 482 minutes or 2% of measurement time) 
were missing, due to face-mask removal because of eating/
drinking or other unspecified reasons. A histogram with the 
distribution of data points is shown in Figure 1. The median 
RR was 13 (10–15, range 0–39). In total, 877 measurements 
(3.6%) were bradypneic. On 262 data points, apnea was 
detected (RR 0 breaths/minute for at least 1 minute, 1.1%). 
Examples of RR values in the PACU and on the ward are 
shown in Figure 2. This shows one patient without any events 
in the PACU or on the ward (Figure 2A), one patient with 
multiple bradypneic events in the PACU and on the ward 
(Figure 2B), and finally one patient with apneic events in the 
PACU and on the ward (Figure 2C). None of the included 
patients in this study required verbal stimulation to breathe, 
mechanical support of ventilation, tracheal intubation, or the 
need for an opioid-reversal agent.
Eleven patients (16%) experienced no respiratory events, 
and 53 patients (78%) experienced at least one bradypneic 
event during the 6-hour study, with a median number of 
Table 1 Patient characteristics, surgery, and pain relief
number of patients analyzed 68
sex, male/female 38/30
age (years) 70 [60–83]
Body-mass index (kg/m2) 26.7 [17.2–40.1]
Weight (kg) 79.6 (13.4)
neck circumference (cm) 38.7 (4.4)
history of snoring, n (%) 38 (56)
Diagnosis of obstructive sleep apnea, n (%) 0
ASA status, n (%)
asa i 6 (9)
asa ii 57 (84)
asa iii 4 (6)
Unknown 1 (1)
Type of surgery, n (%)
general 39 (57)
Orthopedic 11 (16)
Urology 15 (22)
gynecology 3 (4)
Anesthesia technique
general 68
general + epidural/local 19
Type of anesthesia
iV 37
inhalation 21
Unknown 10
Intraoperative opioid type
Remifentanil 17
sufentanil 38
Other 3
Unknown 10
Postoperative pain relief
iV morphine in OT/PaCU 35
iV PCa morphine 5 (following iV  
morphine in OT/PaCU)
Morphine administered in PaCU (mg) 10.3 (4.3)
Morphine use in PaCU (mg) 9.3 (5.2)
Time in PaCU (minutes) 120 (53.8)
Patients who received opioid on the ward 4 (all iV PCa morphine)
Note: Values expressed as mean (sD) or mean [range], unless otherwise stated.
Abbreviations: asa, american society of anesthesiologists; iV, intravenous; OT, 
operating theater; PaCU, postanesthesia care unit; PCa, patient-controlled analgesia.
 
Th
er
ap
eu
tic
s 
an
d 
Cl
in
ica
l R
isk
 M
an
ag
em
en
t d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
12
8.
24
3.
2.
47
 o
n 
27
-J
un
-2
01
9
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Therapeutics and Clinical Risk Management 2017:13submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1094
Broens et al
Figure 1 Observed respiratory rates.
Notes: Respiratory rate data were collected at 1-minute intervals, and represent a data set of almost 24,000 observations from 68 patients.
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Figure 2 examples of collected respiratory rate measurements in three patients (A–C).
Notes: Respiratory rate data were collected at 1-minute intervals. Dotted, horizontal lines indicate the border for bradypnea. Time spent in the postanesthesia care unit 
(PaCU) and on the ward is indicated.
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events per patient of ten (3.5–24). The median duration 
of these events was 1.4 minutes (1–1.6 minutes, range 
1–4.3 minutes). A total of 39 patients (57%) experienced at 
least one apneic event, with a median number of events per 
patient of three (1–11, range 1–28). The median duration 
of an apneic event was 1.6 minutes (1–1.9 minutes, range 
1–5 minutes). A total of 35 patients (51%) experienced both 
apneic and bradypneic episodes, while just four patients (6%) 
had an apneic event without any bradypneic episodes. Finally, 
18 patients (26%) had only bradypneic events.
Patients who experienced bradypnea or apnea did not 
differ from patients without bradypnea or apnea with respect 
to age, body-mass index, sex, American Society of Anesthe-
siologists (ASA) status, positive history of snoring, type of 
surgery, or PACU time. Neck circumference was significantly 
larger in patients with apneic events than in patients without 
apneic events: 39.6 (0.7) cm versus 37.4 (0.8) cm (P,0.05), 
and neck circumference correlated significantly with the 
duration of apnea (P,0.05). In contrast, neck circumference 
was not different for patients with or without bradypneic 
events: 38.7 (0.6) cm versus 38.8 (1) cm (P.0.05). None 
of the studied patient characteristics (age, body-mass index, 
sex, ASA status, positive history of snoring, type of surgery, 
PACU time) were correlated with the number or duration of 
bradypneic or apneic events (data not shown).
The occurrence of apneic and bradypneic events in the 
PACU was a predictor of events on the ward (bradypnea, 
r2=0.4, P,0.001; apnea, r2=0.2, P,0.001; Figure 3). Addi-
tionally, we observed a positive correlation between the 
occurrence of bradypneic events and apneic events (r2=0.4, 
P,0.0001), indicative that both conditions frequently con-
curred. A weak correlation was observed between morphine 
dose and number of observed bradypneic (r2=0.2, P,0.05) 
and apneic (r2=0.3, P,0.05) events in the PACU, but not 
to the number of events on the ward (Figure 4). Finally, we 
observed no difference in the number of apneic and bradyp-
neic events in patients who had received general anesthesia 
combined with an epidural or local block and patients 
who received just general anesthesia (Mann–Whitney test, 
P.0.05).
Discussion
We studied RRs in postoperative patients aged 60 years 
and older following major elective surgery in the PACU 
and on the ward using the RespiR8 device. Continuous and 
reliable RR measurements were obtained during the first 
6 postoperative hours for 98% of the time; data loss because 
of face-mask removal occurred in 2% of measurements. 
A respiratory event occurred in 84% of patients, with frequent 
bradypneic and apneic events in 78% and 57% of patients, 
respectively, with a median of 16.6 bradypneic events per 
patient and 6.6 apneic events per patient.
Various techniques to measure RR continuously in spon-
taneously breathing patients have been developed in recent 
years. These techniques include CO
2
 measurements at the 
mouth and nose, measurement of acoustic signals on the 
skin of the throat, impedance measurements from ECG, and 
measurements of thoracic and abdominal wall movement.11–16 
Figure 3 Correlation between respiratory events measured in the postanesthesia care unit (PaCU) and on the ward.
Notes: (A) Bradypneic events, r2=0.4 (P,0.0001); (B) apneic events, r2=0.2 (P,0.001).
? ?????????
??????????????????????????????????????
???
???
?????
???
???
???
???
????
????
????
???
?
?
??
??
??
??
??
??
? ?? ?? ?? ?? ??
???
???
?????
???
??
???
????
????
????
???
?
?
??
??
??
??????????????????????????????????
? ? ?? ?? ??
??????
 
Th
er
ap
eu
tic
s 
an
d 
Cl
in
ica
l R
isk
 M
an
ag
em
en
t d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
12
8.
24
3.
2.
47
 o
n 
27
-J
un
-2
01
9
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Therapeutics and Clinical Risk Management 2017:13submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1096
Broens et al
Figure 4 Correlation between morphine dose administered in the operating theatre and in the post-anesthesia care unit (PaCU).
Notes: number of bradypneic (blue circles) and apneic (red squares) events in the PaCU (A) and on the ward (B). (A) Bradypnea, r2=0.2 (P,0.05); apnea, r2=0.3 (P,0.05). 
(B) Bradypnea, r2=0.1 (P.0.05); apnea, r2=0.2 (P.0.05).
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Recently a new noninvasive technique was published that 
uses a radar system mounted above the patient’s bed to mea-
sure RR.17 In this study, we used the RespiR8, a small and 
mobile device that relies on the detection of humidity in the 
exhaled air (see Niesters et al9 for a detailed description of 
the RespiR8 measurement technique). The current study, as 
well as our previous validation study, shows that the device 
allows long-term reliable assessment of RR.9 In our sample 
of 68 patients, the device detected multiple events of low RR 
and events with complete cessation of airflow at the mouth. 
It is important to realize that the system does not provide 
information on the cause or location (central or obstructive) 
of the respiratory event. 
Additionally, it is important that although respiratory 
events were frequent, they were short-lived and did not neces-
sitate any intervention, such as verbal stimulation to breathe, 
mechanical ventilation, intubation, admission to the intensive 
care unit (ICU), or any pharmacological intervention. We 
relate this to the fact that our sample was relatively small and 
opioid use on the ward minimal. Our data are supportive of 
the recommendation from national anesthesia societies for 
the continuous monitoring of RR in spontaneously breath-
ing patients who receive potent opioids for pain relief.7,8 
An important observation was that early respiratory events in 
the PACU predict events on the ward. Since opioid use on the 
ward was limited in our patient population, this observation 
suggests that in some patients, respiratory instability persists 
beyond their stay in the PACU. Such prolonged periods of 
instability may be related to underlying disease, surgical 
stress, residual anesthetics and relaxants, opioid use in the 
PACU, or any combination of these factors. Irrespective of 
the cause, the early detection of respiratory events can serve 
as a clinical warning sign, and especially the population with 
early respiratory instability may require RR monitoring on 
the ward, and also in patients who do not consume large 
amounts of opioids.
The amount of morphine use was only weakly correlated 
with the occurrence of respiratory events in the PACU; no 
correlation was observed for events on the ward. The latter 
was expected, given the fact that opioid use on the ward was 
restricted to just four patients. The weak correlation is some-
what surprising, given the fact that the average morphine 
dose was relatively high (0.22 mg/kg). Still, as suggested, 
factors other than opioid consumption alone may have 
played a causal role in the generation of respiratory events 
in our patient population. Whether our findings are related 
to the age-group we tested remains unknown. We recently 
observed more frequent apneic events in an elderly popula-
tion following oxycodone 20 mg intake (with and without 
additional ethanol) relative to a younger population.10 We 
relate these latter findings as well as our current results to 
higher opioid sensitivity and altered pharmacokinetics in 
the elderly, but additionally to alterations in the metabolic 
state, greater stress response to surgery and anesthesia, loss 
of resilience, reduced circulating volume and lean-muscle 
mass, and reduced reserve capacity in the elderly.18–20 These 
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factors may be more pronounced in a certain subcategory of 
elderly patients (“the frail”), which would account for the 
occurrence of respiratory events in many but not all patients. 
At present, we have no reliable way of predicting which 
elderly patients are at increased risk of postoperative respira-
tory events. These findings warrant intensified, continuous 
monitoring of the respiratory status of postoperative elderly 
patients. Further studies are needed to understand fully the 
age effect on the control of breathing following major surgery 
under general anesthesia.
Patients who experienced apneic events had larger neck 
circumference than patients who did not have such events. 
In contrast, no such dichotomy was observed for bradyp-
neic events. Neck circumference is an important predictor 
of upper-airway obstruction in sleep and sedation.21 This 
explains why patients with relatively greater neck circum-
ference had more apneic episodes, most probably related to 
upper-airway obstruction, but not bradypneic events, as these 
are a measure of central respiratory instability.
Our study has a number of limitations. We aimed to 
evaluate the clinical use of the RespiR8 device and quantify 
the occurrence of respiratory events. Consequently, this 
study was not powered to detect any clinical consequences 
of the recorded respiratory events. Oxygen saturation and 
the use of supplemental oxygen in the PACU or on the ward 
were not recorded. Additionally, there was no assessment of 
mental state to detect the occurrence of delirium or postop-
erative cognitive decline. It is thus unclear what the clinical 
significance of the recorded events was. Future, longitudinal 
studies of respiratory events in elderly postoperative patients 
should address these issues. Also, the use of opioids on the 
ward was particularly low. This may have accounted for the 
absence of severe pain on the ward, but we cannot exclude 
that the patient’s age played some role as well (eg, fear of 
opioid use on the ward in elderly patients). It seems likely 
that we would have found a stronger correlation between 
opioid use and respiratory events with a higher total dose of 
administered morphine. This has been observed in patients 
aged 65 years and older on intravenous patient-controlled 
morphine. Interestingly, in that study, respiratory events 
(RR ,10 breaths/minute for at least 2 minutes) occurred in 
78% of patients.4 This incidence is remarkably similar to data 
obtained in our study, and suggests that there are inherent 
opioid-dependent and nonopioid-dependent factors that pre-
dispose to postoperative respiratory events. Additionally, the 
RespiR8 sensor is based on exhaled humidity.9 The presence 
of shallow (opioid-induced) breathing patterns or the applica-
tion of (dry) oxygen flow may change RespiR8 performance, 
and should be taken into account when interpreting our data. 
Finally, periods of sleep or sedation were not recorded. Both 
sleep and sedation can affect breathing patterns, and could 
be informative when analyzing longitudinal RRs.
In conclusion, this is the first long-term data-collection 
study on postoperative RRs in adults aged 60 years and 
older using the RespiR8 system. Almost 80% of patients 
experienced at least one bradypneic period during the 6-hour 
postoperative period, and almost 60% of patients had at 
least one apnea event. These events occurred well into the 
postoperative period, even in the absence of opioid admin-
istration. Known risk factors did not predict which patients 
were at risk for postoperative respiratory depression. Our data 
demonstrate the magnitude of respiratory disturbances in a 
postoperative elderly population, which may relate to pres-
ently unknown patient specific factors. Continuous respira-
tory monitoring during this time frame is warranted in this 
vulnerable patient population.
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